About this episode

This episode discusses the potential of high-dose olanzapine as an alternative to clozapine for treatment-resistant schizophrenia.

In this episode, we explore whether high-dose olanzapine — beyond the FDA-approved 20 mg ceiling — can be a viable strategy for patients with treatment-resistant schizophrenia when clozapine isn't yet an option. Can pushing the dose bridge the gap between partial response and full remission? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CME: Quick Take Vol. 83 Treatment-Resistant Schizophrenia: Should You Consider High-Dose Olanzapine Instead of Clozapine?

More episodes of Psychopharmacology and Psychiatry Updates

• CANMAT Guidelines: Herbs, Supplements, and Depression · July 15, 2026 · 8 min
• Xylazine in the ED: Managing Toxicity · July 10, 2026 · 9 min
• Choosing the First Step in Depression Treatment: A CANMAT Guide · July 5, 2026 · 19 min
• After Delirium Clears: When to Deprescribe? · June 30, 2026 · 15 min
• The Clinician's Guide to Paliperidone & Risperidone LAIs · June 25, 2026 · 15 min
• Antipsychotic Switching: Six Clinical Tips · June 20, 2026 · 12 min

Explore listener stats, chart rankings, contacts and more on the Psychopharmacology and Psychiatry Updates podcast page.